CLINICAL_TRIALS
trial_result
· 2011-06-17
Clinical Trial Update: Efficacy of Rostafuroxin in the Treatment of Essential Hypertension [Phase 2]
Summary
Phase 2 trial evaluating rostafuroxin for essential hypertension has completed; the update summarizes the efficacy findings.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: sigma-tau i.f.r. S.p.A. | Conditions: Essential Hypertension | Phase 2 | Status: COMPLETED